Sequana Medical Plans Summer EU Launch For Fluid Management Device
This article was originally published in The Gray Sheet
Executive Summary
Sequana Medical anticipates a European commercial launch this summer for its ALFApump system, a battery-powered implantable device designed to safely remove excess fluid from the abdomen in patients with liver disease.
You may also be interested in...
New Products In Brief
Siemens’ D-dimer assay
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.